Brazilian shipping group Belov Engenharia has signed new contracts with Petrobras for the supply of four shallow diving support vessels (SDSV) to assist in operations in the South American nation.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
US biopharmaceutical company Gilead Sciences agreed to buy Ouro Medicines, which is developing an antibody-based medicine for autoimmune diseases licensed from China’s Keymed Biosciences, in a deal ...
Gilead Sciences is paying $1.67 billion for a T-cell engager (TCE) company via a front-loaded deal that could also give new meaning to its partner Galapagos. By acquiring GSK-founded Ouro Medicines, ...
Gilead Sciences GILD1.18%increase; green up pointing triangle plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion and develop the assets from ...
-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s Inflammation Portfolio -- -- Gilead Intends to Enter into a Strategic ...
Gilead will pay $1.675 billion upfront plus up to $500 million in milestones to obtain OM336, positioning BCMA-targeted T-cell engagement as an “immune reset” strategy in autoimmune cytopenias. OM336 ...
Gilead Sciences Inc. said it would acquire Ouro Medicines, a closely held company testing novel antibody drugs against autoimmune diseases, for as much as $2.18 billion. Under terms of the deal, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company ...
Gilead Sciences plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion. Under the terms of the deal, Gilead would buy all of the outstanding equity ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Brazilian ski racer Lucas Pinheiro Braathen swiped away the competition with a powerful final run in the Olympic giant slalom on Saturday, winning gold and earning South America's first-ever medal at ...